We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Anyone supplying these types of tests should temporarily stop this service.
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
A new online reporting site, dedicated to reporting any suspected side effects from medicines, future vaccines and incidents involving medical equipment relating to COVID-19 treatment, has today been launched.
An increasing number of bogus medical products being sold through unauthorised websites claiming to treat or prevent COVID-19 are being investigated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Adapted breathing aid developed by UCL, UCLH and Mercedes Formula One provides vital technology to NHS.
Patients are urged to stop taking 5mg ulipristal acetate as soon as possible and contact a healthcare professional for advice on alternative treatments.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
First published during the 2019 to 2022 Johnson Conservative government
The Medicines and Medical Devices Bill introduces new safety measures, increases the professions that can prescribe low-risk medicines and allows hospitals to develop personalised medicines.
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
Teva UK Ltd is recalling unexpired stock of certain batches of 2 types of Ranitidine medicines used to treat conditions such as heartburn and stomach ulcers.
Patients who carry Emerade auto-injector pens for the emergency treatment of severe acute allergic reactions (anaphylaxis) to foods, medicines or insect stings are being reminded of existing advice to carry 2, in-date pens w…
The MHRA has taken action to ensure product safety for patients supplied with total parenteral nutrition (TPN) bags from the Calea UK (part of Fresenius Kabi) manufacturing facility in Runcorn, Cheshire
For the first time, people aged 16 years and older will be able to buy a screening test patch from general sale outlets to see if they are allergic to PPD.
Drivers who treat their diabetes with insulin will have greater choice in how they test their glucose levels under new guidelines published today by the DVLA.
The Health and Social Care Secretary has written 2 letters to industry about contingency plans in the unlikely event of a no-deal Brexit.
First published during the 2016 to 2019 May Conservative government
From 1 April 2015, MHRA will be issuing Certificates of Free Sale for medical devices.
How MHRA and OxSonics help cancer drugs go the extra mile.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).